Abstract
In the recent years, so-called cell-penetrating peptides (CPPs) have been in constant study due to its ability to penetrate cell membranes. CCPs are characterized by a length of less than 60 amino acids, its highly cationic nature and by a positive net charge at neutral pH. For the CPPs either an endocytic or non-endocytic uptake mechanism has been identified. This work presents the computational polarity index method that is able to predict the uptake mechanism of CPPs with an accuracy of 72% in a double-blind test. This was achieved by reading the peptide sequence and measuring the polarity as one single physico-chemical property. The method was verified by extracting all peptides from the CPPsite database (April 21, 2014) and its efficiency was tested with seven specialized databases of peptides and proteins.
Keywords: Polarity index method, cell-penetrating peptides, endocytic pathway, non-endocytic pathway.
Current Bioinformatics
Title:Identification of Uptake Mechanism of Cell-Penetrating Peptides by their Polar Profile
Volume: 10 Issue: 5
Author(s): Carlos Polanco, José Lino Samaniego Mendoza, Thomas Buhse, Jorge Alberto Castañón González, Arturo Gimbel and Marili Leopold Sordo
Affiliation:
Keywords: Polarity index method, cell-penetrating peptides, endocytic pathway, non-endocytic pathway.
Abstract: In the recent years, so-called cell-penetrating peptides (CPPs) have been in constant study due to its ability to penetrate cell membranes. CCPs are characterized by a length of less than 60 amino acids, its highly cationic nature and by a positive net charge at neutral pH. For the CPPs either an endocytic or non-endocytic uptake mechanism has been identified. This work presents the computational polarity index method that is able to predict the uptake mechanism of CPPs with an accuracy of 72% in a double-blind test. This was achieved by reading the peptide sequence and measuring the polarity as one single physico-chemical property. The method was verified by extracting all peptides from the CPPsite database (April 21, 2014) and its efficiency was tested with seven specialized databases of peptides and proteins.
Export Options
About this article
Cite this article as:
Polanco Carlos, Samaniego Mendoza Lino José, Buhse Thomas, Alberto Castañón González Jorge, Gimbel Arturo and Sordo Leopold Marili, Identification of Uptake Mechanism of Cell-Penetrating Peptides by their Polar Profile, Current Bioinformatics 2015; 10 (5) . https://dx.doi.org/10.2174/1574893610666151008011903
DOI https://dx.doi.org/10.2174/1574893610666151008011903 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Signaling Function of the IL-13Rα2 Receptor in the Development of Gastrointestinal Fibrosis and Cancer Surveillance
Current Molecular Medicine Cancer Therapy: Targeting Cell Cycle Regulators
Anti-Cancer Agents in Medicinal Chemistry Recent Development in Targeting PI3K-Akt-mTOR Signaling for Anticancer Therapeutic Strategies
Anti-Cancer Agents in Medicinal Chemistry Molecular Pharmacology and Pharmacogenomics of Artemisinin and its Derivatives in Cancer Cells
Current Drug Targets Exploring Protein-Protein and Protein-Ligand Interactions in the Immune System using Molecular Dynamics and Continuum Electrostatics
Current Physical Chemistry Nanotechnology on Duty in Medical Applications
Current Pharmaceutical Biotechnology Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision
Anti-Cancer Agents in Medicinal Chemistry Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Current Pharmaceutical Design Exploiting APC Function as a Novel Cancer Therapy
Current Drug Targets Understanding the Interaction Between Human Serum Albumin and Anti-Bacterial/ Anti-Cancer Compounds
Current Pharmaceutical Design Microsatellite Instability as a Predictor of Outcomes in Colorectal Cancer in the Era of Immune-Checkpoint Inhibitors
Current Drug Targets Small-molecule Inhibitors of Epigenetic Mutations as Compelling Drugtargets for Myelodysplastic Syndromes
Current Cancer Drug Targets Theranostic Radiopharmaceuticals Targeting Cancer-Associated Fibroblasts
Current Radiopharmaceuticals Insulin Resistance and Endothelial Dysfunction: A Mutual Relationship in Cardiometabolic Risk
Current Pharmaceutical Design Modulating Mitochondria-Mediated Apoptotic Cell Death through Targeting of Bcl-2 Family Proteins
Recent Patents on DNA & Gene Sequences Synthesis of Phenol-derivatives and Biological Screening for Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry The Role of Celecoxib as a Potential Inhibitor in the Treatment of Inflammatory Diseases - A Review
Current Medicinal Chemistry Nanotech Revolution for the Anti-Cancer Drug Delivery through Blood- Brain-Barrier
Current Cancer Drug Targets Anticancer Properties of Amino Acid and Peptide Derivatives of Mycophenolic Acid
Anti-Cancer Agents in Medicinal Chemistry Senescence and Cell Death Pathways and Their Role in Cancer Therapeutic Outcome
Current Medicinal Chemistry